In this review article from Biomarkers in Medicine, researchers explore the current application of blood-based markers to assess amyloid-β pathology.
Browsing: amyloid beta
A recent study has implicated that sticky proteins associated with neurodegenerative diseases could be transferred in mouse models.
Researchers have demonstrated that a DNA vaccine tested in mice is effective at reducing accumulation of tau and beta-amyloid proteins associated with Alzheimer’s disease.
Scientists have discovered a vicious feedback loop underlying brain degeneration in Alzheimer’s, which may explain why many drug trials have failed.
Researchers have suggested that anti-amyloid therapies would be most effective before individuals reach the threshold for preclinical Alzheimer’s disease.
A recent study suggests that beta-amyloid may be transmissable during surgery, but how strong is the evidence?
Researchers have observed improvements in the cognitive function of mice after reversing the formation of beta-amyloid plaques.
A collaborative study from researchers in Poland and Sweden has presented a novel combination of mechanisms that may lead to neuronal cell death in Alzheimer’s disease.
Researchers have discovered that an experimental drug appears to block the flow of toxic ions thought to cause Alzheimer’s.
For the first time, researchers have been able to examine the exact link between amyloid- β and tau in an animal model of the Alzheimer’s brain, providing hope for new therapeutic targets.